Virgin Galactic Holdings, Inc. vs 22nd Century Group Inc — how do they compare? Virgin Galactic Holdings, Inc. trades at $2.84 (market cap $445.69M), while 22nd Century Group Inc trades at $0.81 (market cap $621.67K). The key difference: Virgin Galactic Holdings, Inc. is far larger — about 716.9× 22nd Century Group Inc's market cap, and Virgin Galactic Holdings, Inc. is trading nearer its 52-week high, 22nd Century Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Virgin Galactic Holdings, Inc. for 69 Days and 22nd Century Group Inc for 32 Days on average.
| SPCE | XXII | |
|---|---|---|
Market Cap | $445.69M | $621.67K |
Volume | 5,128,850 | 45,625 |
Sector | Industrials | Consumer Staples |
52-Week High | $7.52 | $483.00 |
52-Week Low | $2.17 | $0.80 |
Typical Hold Time | 69 Days | 32 Days |
Enterprise Value | $409.68M | -$3.69M |
Signals from Pluang's Aura AI — not financial advice
Virgin Galactic (SPCE) trades at $2.94, down 2.33% on the day, reflecting ongoing investor concerns despite recent earnings beats. The stock shows bearish technical signals with key support at $3.00, while fundamentals reveal significant challenges including negative profit margins (-23,867.44% net income margin) and substantial cash burn. Recent news highlights management's guidance for positive cash flow by 2027 but also delays in commercial Delta flights to February 2027.
The outlook remains high-risk with Wall Street divided (29% buy, 41% hold, 29% sell). Investment opportunity hinges on successful commercialization of space tourism, but risks include persistent losses, high debt levels, and execution delays. The company's path to profitability remains uncertain despite strong ticket demand indications.
XXII trades at $0.8116, down 8.96% in the last session, with a bearish technical signal from moving averages. The company shows negative profitability metrics including -76.01% net income margin and -284.5% ROE, though valuation ratios appear low with P/S of 0.08 and P/B of 0.03. Recent news highlights regulatory progress in reduced-nicotine tobacco initiatives in France and Europe.
While analyst consensus is 75% buy with a $1,240 price target suggesting significant upside, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock faces execution risk in commercializing its reduced-nicotine platform amid ongoing losses.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Virgin Galactic Holdings Inc. develops space vehicles. The Company designs exploration technology such as missiles, rockets, and other related equipment. Virgin Galactic Holdings serves customers in the United States.
Read more on SPCE →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →